Stage FocusPre-Seed, Seed, Series A
GeographyEurope, US, China
TypeCVC
Last Activity2025
Industry Focus
Industries
BiotechMedtechAI
Technical BenchStrong
Investor TypeCVC
ExposureMostly DeepTech Investments
Bio
The Boehringer Ingelheim Venture Fund was established in 2010 as an evergreen CVC, growing from an initial €100M allocation to €350M (roughly $400M). The fund has made 70+ investments including fund-in-fund positions, with 40+ currently in the portfolio.
Focus areas include immuno-oncology, regenerative medicine, infectious diseases, and digital health. Check sizes run €500K to €15M with a 5-7 ye...
Similar Funds
HV
Hummingbird VC
London, United Kingdom
GeneralistBiotechAIBlockchainPre-SeedSeed
AC
Actions Capital
New York, United States
GeneralistBiotechRoboticsMedtechPre-SeedSeed
PG
Pool Global Partners
Toronto, Canada
DeepTech NativeBiotechMedtechAIPre-SeedSeed
PC
Practica Capital
Vilnius, Lithuania
GeneralistBiotechSynthetic BiologyMedtechPre-SeedSeed
S
SmartGateVC
Yerevan, Armenia
DeepTech NativeBiotechNeurotechAIPre-SeedSeed
Ao
Alliance of Angels
Seattle, United States
GeneralistBiotechHardwareAIPre-SeedSeed